explore -WSS

explore

author：knowledge 2025-09-06 09:57:09 - browse：6

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Cue Health, Covid

hotspot

WSS

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Bird flu surveillance in wastewater gets boost from consortium

UnitedHealth argues against case alleging wrongful AI care denials

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Affordable Connectivity Program vital to health care, experts say

Investigation reveals sickle cell patients pressured into sterilizations

Wikipedia

explore

entertainment

Walensky prepares to leave CDC — and Congress — behind

Digital health: a case of mistaken identity

In Memoriam: Notable people who died in 2023

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Malaria cases in Florida and Texas: Here’s what you need to know

I learned firsthand about improving diversity in clinical trials

Virginia high school admissions case could be legal follow

Vir antibody drug aimed at influenza A fails in clinical trial

explore

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

As a primary care physician, here's how I hope to partner with AI

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

FDA poised to publish guidelines for clinical trial diversity

Investigation reveals sickle cell patients pressured into sterilizations

focus

hotspot

explore

hotspot